NephroGenex Inc. NRX +230% - After hours Tuesday the company announced positive results from the QT study of Pyridorin.
RedHill Biopharma Ltd. ADR RDHL +48% - Shares are higher on Wednesday following the company’s announcement that the United Kingdom has validated its marketing authorization application for its Bekinda drug.
Meadowbrook Insurance Group Inc. MIG +19% Fosum International Announced they will acquire Meadowbrook for $8.65 per share or $433 million.
Cytokinetics Inc. CYTK +19% - Shares continue higher following a price target increase to $18 per share by Roth Capital analysts.
Tekmira Pharmaceuticals Corporation TKMR +13% - On Wednesday, the company provided an update on its TKM-PLK1 Phase I/II clinical study.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
